An interventional study of Exercise and Standart therapy in Migraine, sponsored by Mustafa Kemal University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Mustafa Kemal University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Migraine Disorders with a site in Turkey — 20 open to participants now, 25 under way, 3 of them phase 3. Migraine Disorders · Turkey.
Among the 92 studies in Migraine Disorders with a site in Turkey, this one is the 54th largest by planned enrollment of the 69 interventional ones that give a count, is one of 9 that started in 2026, is one of 56 with no phase, reaches primary completion later than 13 of the 24 other live ones, and was the 80th registered.
1,660 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.
Browse Migraine Disorders studies →20 of the 92 studies in Migraine Disorders with a site in Turkey are open now. Recruiting first, the newest first:
Ankara Yildirim Beyazıt University · Sites in Turkey
Ages 18–55
Bozok University · Sites in Turkey
Ages 18–65
Ankara Yildirim Beyazıt University · Sites in Turkey
Ages 18–55 · Healthy volunteers
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Women only
Hospital Universitari Vall d'Hebron Research Institute · Sites in Turkey, United States, Argentina and 10 more countries
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 80 across 1,271 interventional studies indexed under Migraine Disorders.
Median enrollment 73 across the 69 interventional studies, 130 across the 23 observational. Of the 63 that completed or were terminated, 5 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 92 have an industry lead sponsor. The 10 most frequent:
Mustafa Kemal University is the lead sponsor of 78 studies on the registry; 18 are open to participants now.
Mustafa Kemal University has 1 study filed under Migraine Disorders — fewer than ten, so there is no comparison to draw.
5 of the studies in Migraine Disorders with a site in Turkey that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04965675Phase 3H. Lundbeck A/SA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine | 2027-03-26 |
| NCT05897320Phase 3H. Lundbeck A/SA Study of Eptinezumab in Pediatric Participants With Episodic Migraine | 2027-07-06 |
| NCT06468189Istanbul Medipol University HospitalClinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine | 2026-11 |
| NCT07261384Hacettepe University"Personalized Physiotherapy for Migraine: Effects on Pain, Fatigue, and Physical Function" | 2027-01-30 |
| NCT07657377Ankara Yildirim Beyazıt UniversityThe Effects of Physiotherapy in Migraine | 2027-08 |
Add all 5 to your calendar (.ics) → With an account.
Among the 92 studies in Migraine Disorders with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the Jenkins Sleep Scale (JUS), and quality of life using the Headache Impact Test. Assessment of functional status, sleep quality, and quality of life will be performed before treatment and after treatment (at the end of week 8).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive body awareness therapy in addition to standard treatment. The exercise program will be implemented twice over an eight-week period.
Behavioral: Exercise · Behavioral: Standart therapy
Participants in this group will receive standard treatment without the additional body awareness therapy.
Behavioral: Standart therapy
Participants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population.
Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.
Pain Diary
The severity, duration, and frequency of headaches during attacks will be recorded daily by the participants.
Time frame: Individuals will be asked to regularly complete a pain diary during the 4-week period before the program, during the program, and during the 4-week follow-up period after the training is completed.
Functional status
The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine.
Time frame: Baseline and at the end of the 8-week intervention
Sleep quality
Individuals' sleep quality will be assessed using the Jenkins Sleep Scale.
Time frame: Baseline and at the end of the 8-week intervention
Quality of life related to headaches.
The Headache Impact Test will be used to assess the impact of headache on quality of life.
Time frame: Baseline and at the end of the 8-week intervention
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2026 to primary completion in Mar 2026, 2 months.
Of 310 non-industry interventional studies with no phase under Migraine Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 2 months is below that.
Counting every sponsor, half of 360 studies reached it within 15 months; a quarter within 7 and three quarters within 33.
Completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Nov 2026, on Oct 27, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mustafa Kemal University